Inventor · disambiguated record
Amir S. Razai
Also filed as: RAZAI AMIR · RAZAI AMIR S
12 granted patents·9 pending applications·116 citations·filing 2013–2025
89Inventor score
Top patents by PatentIndex Score
21 records- 0197US9045541B2CD47 antibodies and methods of use thereofINHIBRX LLC·Filed 2013·Granted Jun 2, 2015·78 cites·21 claims
- 0295US9663575B2CD47 antibodies and methods of use thereofINHIBRX LP·Filed 2015·Granted May 30, 2017·22 cites·22 claims
- 0388US10501551B2Multivalent and multispecific 41BB-binding fusion proteinsINHIBRX INC·Filed 2017·Granted Dec 10, 2019·7 cites·64 claims
- 0484US11117972B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 0584US10093742B2Multispecific GITR-binding fusion proteins and methods of use thereofINHIBRX INC·Filed 2016·Granted Oct 9, 2018·4 cites·57 claims
- 0684US2025250349A1Uses of pdl1-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0783US10308720B2Multivalent and multispecific DR5-binding fusion proteinsINHIBRX INC·Filed 2016·Granted Jun 4, 2019·3 cites·24 claims
- 0883US2024376220A1Multivalent and Multispecific DR5-Binding Fusion ProteinsINHIBRX BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0981US12187804B2Multivalent and multispecific 41BB-binding proteinsINHIBRX BIOSCIENCES INC·Filed 2022·Granted Jan 7, 2025·0 cites·12 claims
- 1076US11976126B2Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cellsINHIBRX INC·Filed 2021·Granted May 7, 2024·0 cites·24 claims
- 1173US2024166744A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX INC·Filed 2023·Application pending·0 cites
- 1272US12227584B2Multivalent and multispecific OX40-binding fusion proteinsINHIBRX BIOSCIENCES INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 1371US11566078B2PDL1-binding proteinsINHIBRX INC·Filed 2019·Granted Jan 31, 2023·0 cites·22 claims
- 1471US2021317205A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX INC·Filed 2021·Application pending·0 cites
- 1570US11117973B2Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasmsINHIBRX INC·Filed 2019·Granted Sep 14, 2021·0 cites·39 claims
- 1663US10844129B2Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acidsINHIBRX INC·Filed 2018·Granted Nov 24, 2020·0 cites·34 claims
- 1756US2016251435A1Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereofINHIBRX LLC·Filed 2015·Application pending·0 cites
- 1853US2014140989A1Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use ThereofINHIBRX LLC·Filed 2013·Application pending·0 cites
- 1951US2017320958A1Multivalent and multispecific gitr-binding fusion proteinsINHIBRX LP·Filed 2017·Application pending·0 cites
- 2049US2025263488A1Methods and systems for identifying or treating central nervous systems diseaseARIALYS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2149US2017198051A1Multivalent and multispecific ox40-binding fusion proteinsINHIBRX LP·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amir S. Razai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →